Creative Edge Nutrition, Inc. (OTC : FITX)

lean_largeCreative Edge Nutrition, Inc is a development-stage company that produces and markets nutraceutical and health supplements under the brand name Cenergy. In 2013, it established a partially owned subsidiary called CEN Biotech, Inc to supply pharmaceutical-grade medical cannabis to Canada.

The Cenergy brand has a variety of tablets, capsules, and powders for different aspects of health. These include weight management, energy, fitness, and well-being. The brand also has a “Natural” product line featuring hemp products such as tea and coffee additives. In addition, it has presented a line of Cenergy sports apparel and bags. Cenergy’s website complements all these with free workout, nutrition, and supplement plans.

Meanwhile, CEN Biotech is processing its application for a license to produce and supply medical marijuana under Canada’s Marijuana for Medical Purposes Regulation (MMPR). With an 80,000-square feet facility in Ontario, this subsidiary aims to cultivate and sell medicinal dried marijuana, as well as provide educational programs and form clinical research partnerships.

More recently, Creative Edge Nutrition has acquired another subsidiary, Hemp Technologies, Inc, through which it is breaking into the global hemp market. The company has also announced that it will be among the first in America to offer medical marijuana insurance.

Creative Edge Nutrition began in 2009 as a subsidiary of Laufer Bridge Enterprises, Inc, a nutrition company. The company then changed to its current name in 2012.

With a market cap of USD 26.24 M, Creative Edge Nutrition, Inc is currently traded in the OTC market as FITX. Its top executives include Bill Chaaban, CEO and President; Paul R. Thomas, Co-founder and Senior VP; Reid Stone, Executive VP, Secretary, and Treasurer; Leonard K. Armenta, Jr, VP of Brand Management and Marketing; and Joel Stohlman, Consultant and Advisor.


[hungryfeed max_items=”5″ template=”1″ url=”feed://feeds.finance.yahoo.com/rss/2.0/headline?s=CEN&region=US&lang=en-US”]